Rockwell Medical, Inc. ($RMTI) will release its financial and operational results for the second quarter ended June 30, 2024 on Thursday, August 8, 2024. The Company will issue a press release at 6:00am ET followed by a live conference call and webcast at 8:00am ET. #earnings https://bit.ly/3zLdp9C
Rockwell Medical, Inc.
Pharmaceutical Manufacturing
Wixom, Michigan 3,106 followers
Driven to Deliver Life-Sustaining Dialysis Solutions
About us
Rockwell Medical (Nasdaq: RMTI) is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide.
- Website
-
http://www.rockwellmed.com
External link for Rockwell Medical, Inc.
- Industry
- Pharmaceutical Manufacturing
- Company size
- 201-500 employees
- Headquarters
- Wixom, Michigan
- Type
- Public Company
- Founded
- 1995
Locations
-
Primary
30142 S Wixom Rd
Wixom, Michigan 48393, US
-
604 High Tech Ct
Greer, South Carolina 29650, US
-
4051 Freeport Pkwy
Suite 100
Grapevine, Texas 75019, US
Employees at Rockwell Medical, Inc.
Updates
-
Please join Rockwell Medical, Inc. in welcoming Melissa Thon, Human Resources Generalist, to our team!
-
-
Congratulations to Tim Chole on his promotion to Chief Commercial Officer! Tim joined Rockwell Medical, Inc. in December 2019 as SVP, Sales and Marketing. In November 2022, following our new business strategy announcement, Tim led our commercial organization and supported Rockwell's vision to focus our efforts on enhancing our revenue-generating businesses and driving Rockwell Medical towards profitability. https://bwnews.pr/3X2VJjx #promotion #congratulations #Dialysis #ESKD #hemodialysis #renalcare
-
-
Remembering and honoring those who made the ultimate sacrifice in service to our country and their families. #RememberAndHonor #Gratitude #MemorialDay2024 #USA
-
Rockwell Medical, Inc. (Nasdaq: RMTI) Announces First Quarter 2024 Results, Raises 2024 Guidance ◉ Reports record net sales of $22.7 million for the first quarter of 2024, an increase of 25% over net product sales and a 15% increase over net sales for the same period in 2023. ◉ Reports record gross profit of $3.1 million for the first quarter of 2024, an increase of 18% over the same period in 2023. ◉ Raises guidance for net sales, gross profit, and profitability on an adjusted EBITDA basis for the full-year 2024. Conference call / Webcast will be held today (May 15, 2024) at 8:00am ET Call Details: (888) 660-6347 // (International) 1 (929) 201-6594 // Passcode: 4944610 Webcast: https://lnkd.in/gHp-QuPq Press Release: https://bit.ly/3yjUYIw $RMTI #earnings #hemodialysis #dialysis #dialysispatients #DialysisClinic #EndStageKidneyDisease #ESKD
-
-
Please join Rockwell Medical, Inc. in welcoming the newest members of our team! ◉ Nicholas Fanslau, Controller, brings more than 15 years' experience in accounting and financial reporting. ◉ Andrew B., Director, Sales Operations, brings more than 20 years' cross-functional experience in sales, operations, technology and analytics.
-
-
We are pleased to announce that Rockwell Medical, Inc. entered into a product purchase agreement with one of the largest health systems in the Mountain West region of the United States. Under the terms of the agreement, Rockwell Medical will supply this health system with its liquid and dry acid and bicarbonate #hemodialysis concentrates, cleaning agents, hemodialysis concentrates mixers and any additional products offered by Rockwell Medical. https://bit.ly/4457IyI #dialysis #DialysisPatients #DialysisClinics #EndStageKidneyDisease #ESKD #growth #expansion
-
-
Rockwell Medical, Inc. ($RMTI) will release its financial and operational results for the first quarter ended March 31, 2024 on Tuesday, May 14, 2024. The Company will issue a press release at 6:00am ET followed by a live conference call and webcast at 8:00am ET. #earnings https://bit.ly/4aSKg9S
-
-
Rockwell Medical, Inc. is pleased to announce that it is expanding its global distribution in the Dominican Republic and Bermuda, entering into new and expanded distribution agreements with BioNuclear and Atlantic Medical International, respectively. The global reach of our hemodialysis concentrates products continues to grow. Through distribution arrangements such as these, we continue to execute against our strategy and vision to become the leading supplier of hemodialysis concentrates worldwide. https://bit.ly/3PO2Esh #hemodialysis #dialysis #dialysispatients #DialysisClinics #EndStageKidneyDisease #ESKD #globalexpansion
-